ReviewCancer Lett2016

Current progress in immunotherapy for pancreatic cancer.

DOI 10.1016/j.canlet.2015.12.020 ↗ OpenAlex, retrieved 5 November 2026

Journal: Cancer Lett
Published: 23 December 2015
Citations: 159
Type: Review

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Trials 1

BackgroundCombined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma NCT05955157 ↗

Grants 4

Dissecting the mechanisms of immune tolerance within the pancreatic tumor's micro K23CA148964 ↗
Core 2: Biospecimen/Pathology Core P50CA062924 ↗
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer R01CA169702 ↗
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial R01CA197296 ↗